Treatment of severe obsessive-compulsive disorder with fluvoxamine
- 1 August 1987
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 144 (8) , 1059-1061
- https://doi.org/10.1176/ajp.144.8.1059
Abstract
Ten obsessive-compulsive patients received single-blind treatment with fluvoxamine, a selective serotonin reuptake inhibitor, for several weeks following at least 2 weeks of placebo. The group showed significant improvement, as measured by several clinical scales and self-ratings; six patients were judged responders. Fluvoxamine appears effective in treating severe obsessive-compulsive disorder.This publication has 10 references indexed in Scilit:
- Clinical characteristics and family history in DSM-III obsessive- compulsive disorderAmerican Journal of Psychiatry, 1986
- Obsessive-compulsive disorder and serotonin: Is there a connection?Biological Psychiatry, 1985
- Fluoxetine in the treatment of obsessive compulsive disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1985
- Lifetime Prevalence of Specific Psychiatric Disorders in Three SitesArchives of General Psychiatry, 1984
- A Double Blind Study of Imipramine versus Zimelidine in Treatment of Obsessive Compulsive NeurosisPharmacopsychiatry, 1984
- A double‐blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.British Journal of Clinical Pharmacology, 1983
- Fluvoxamine Influences Serotonergic System in the Brain: Neurochemical EvidenceNeuropsychobiology, 1983
- Fluvoxamine maleate, a serotonergic antidepressant; A comparison with chlorimipramineProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Clomipramine Treatment of Obsessive-Compulsive DisorderArchives of General Psychiatry, 1980
- L-tryptophan in obsessive-compulsive disordersAmerican Journal of Psychiatry, 1977